Brokerages Set SelectQuote, Inc. (NYSE:SLQT) Target Price at $3.88

Shares of SelectQuote, Inc. (NYSE:SLQT) have been given a consensus recommendation of “Hold” by the five brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $3.8750.

Several research firms have weighed in on SLQT. Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a research note on Monday, December 1st. Wall Street Zen downgraded shares of SelectQuote from a “hold” rating to a “sell” rating in a research report on Saturday, November 15th. Zacks Research raised shares of SelectQuote from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 22nd. Finally, Royal Bank Of Canada lowered their target price on shares of SelectQuote from $6.00 to $5.00 and set a “sector perform” rating for the company in a research note on Thursday, November 20th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SLQT. TriaGen Wealth Management LLC lifted its holdings in shares of SelectQuote by 2,873.2% during the 2nd quarter. TriaGen Wealth Management LLC now owns 1,055,500 shares of the company’s stock valued at $2,512,000 after purchasing an additional 1,020,000 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in SelectQuote by 71.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,931,037 shares of the company’s stock worth $4,596,000 after buying an additional 803,594 shares during the period. American Century Companies Inc. lifted its stake in SelectQuote by 75.4% in the second quarter. American Century Companies Inc. now owns 1,773,882 shares of the company’s stock valued at $4,222,000 after buying an additional 762,425 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of SelectQuote by 7.0% in the first quarter. Vanguard Group Inc. now owns 7,880,173 shares of the company’s stock valued at $26,320,000 after buying an additional 516,752 shares during the period. Finally, Qube Research & Technologies Ltd increased its position in shares of SelectQuote by 545.8% during the second quarter. Qube Research & Technologies Ltd now owns 584,577 shares of the company’s stock worth $1,391,000 after acquiring an additional 494,054 shares in the last quarter. 34.59% of the stock is currently owned by institutional investors.

SelectQuote Price Performance

Shares of SLQT stock opened at $1.37 on Friday. The firm’s 50 day moving average price is $1.75 and its two-hundred day moving average price is $2.01. The company has a debt-to-equity ratio of 1.06, a quick ratio of 5.42 and a current ratio of 5.42. SelectQuote has a 52-week low of $1.33 and a 52-week high of $6.86. The stock has a market cap of $240.20 million, a PE ratio of 27.30 and a beta of 1.21.

SelectQuote (NYSE:SLQT) last issued its earnings results on Thursday, November 6th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.01. SelectQuote had a net margin of 3.95% and a return on equity of 10.41%. The company had revenue of $328.81 million during the quarter, compared to analysts’ expectations of $323.68 million. As a group, analysts forecast that SelectQuote will post -0.07 EPS for the current year.

SelectQuote Company Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.